Actelion Pharmaceuticals is a provider of solutions for the unmet medical needs. This biopharmaceutical company was founded on 17 December 1997. Based in Switzerland, the company supplies their products to over 50 countries across the world.
Zavesca 100 mg Miglustat Hard Capsules from Actelion Pharmaceuticals are intended for patients suffering from type 1 Gaucher disease. They are suitable for people who are not comfortable with the enzyme replacement therapy. These capsules can also be used to treat the Niemann-Pick type C disease, which results in disturbances of neurological functions if untreated.
Zavesca 100 mg Miglustat Hard Capsules are intended for the oral treatment. Patient with mild to moderate type 1 Gaucher disease can be benefitted by these capsules. Zavesca capsules have to be swallowed with water and can be taken with or without food. Before using these capsules, it is advisable to get the guidance from a doctor. Pregnant women are not recommended to consume Zavesca 100 mg Miglustat Hard Capsules. For adults with type 1 Gaucher disease, a capsule three times a day is wise. In case of Niemann-Pick type C disease, adults and adolescents have to take a minimum of 6 capsules per day.